The Art and Science of Lung Transplantation Remote Monitoring

Course Description

This session examines the lung transplant patient journey with a focus on the design and implementation of remote monitoring and tele-rehabilitation programs for post-transplant care. Using a large regional transplant program as a model, the session explores how hybrid care delivery supports patients who travel long distances for assessment and surgery while maintaining continuity, safety, and functional recovery after transplant.

Participants will learn how tele-rehabilitation is integrated into post-operative care, including patient selection, technology platforms, home monitoring tools, and low-cost exercise equipment strategies. The course reviews typical recovery timelines, outpatient follow-up structures, and multidisciplinary rehabilitation workflows, along with approaches to remote assessment of exercise capacity and physical function. Operational considerations — such as digital access, patient engagement, device reliability, staffing models, and technical support — are discussed alongside current challenges and future directions.

Learning Objectives

At the conclusion of this activity, learners will be able to:

Describe the key components of a lung transplant tele-rehabilitation and remote monitoring program, including patient selection, technology platforms, home-based assessment tools, and multidisciplinary staffing models.
Identify operational and clinical considerations for implementing tele-rehabilitation after lung transplantation, including equipment needs, patient engagement strategies, and limitations related to digital access and measurement reliability.

Faculty

Kathryn Hughes, MSN, APRN, AGACNP, Vanderbilt Medical Center, Nashville, TN, USA (Chair)
Meg Fregoso, MSN, NP-BC, CCTC, Inova Fairfax Hospital, Falls Church, VA, USA (Chair)
James Walsh, PhD, BPhty, Physiotherapist, The Prince Charles Hospital, Brisbane, Australia

FACULTY DISCLOSURES

The Heart Failure Society of America (HFSA) and the International Society for Heart and Lung Transplantation (ISHLT) are committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24-months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity.

Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interest have been resolved in accordance with the ACCME Updated Standards for Commercial Support.

The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest:

Kathryn Hughes, MSN, APRN, AGACNP
Meg Fregoso, MSN, NP-BC, CCTC
James Walsh, PhD, BPhty, Physiotherapist

Off-Label Disclosure

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Continuing Education Credit Statement

In support of improving patient care, this activity is jointly provided by the Heart Failure Society of America (HFSA) and the International Society for Heart and Lung Transplantation (ISHLT). The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

The Heart Failure Society of America designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 0.50 contact hours. Learners should claim only the credit commensurate with the extent of their participation in the activity.

The Heart Failure Society of America has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

ABTC Logo
As a designated Approved Provider by the American Board for Transplant Certification (ABTC), the International Society for Heart and Lung Transplantation grants up to 2.25 Category 1 Continuing Education Points for Transplant Coordinators (CEPTCs) for this offering. CEPTC Approval Number: 221-32.
This activity, as part of the bundle, offers 0.50 CEPTCs

Successful completion of this activity includes the completion of the post-course evaluation.

Summary

Availability:

On-Demand

Expires on Mar 17, 2028

Cost:

FREE

Credit Offered:

0.5 CEPTC Credit

0.5 CME Credit

0.5 NCPD Credit

0.5 AAPA CME Credit

Create Account